More News

Breaking News: Merial Purchases Legend and Marquis from Bayer

The addition is a boost to an already strong equine portfolio of products.

By Horse Journal Staff

December 17, 2014

This article from the December 2014 issue of Horse Journal.

Merial announced today that it has acquired Thinkstock photo
Credit: Thinkstock photo
Legend and Marquis from Bayer HealthCare. Currently both products are primarily available in the United States and Canada, but Merial plans to broaden their availability worldwide.

Legend, of course, is the injectable joint product. Marquis is a n antiprotozoal paste that is FDA-approved for equine protozoal myeloencephalitis (EPM), a disease that affects the central nervous system in horses.

The purchase is expected to finalize in 2015, adding to Merial's equine healthcare portfolio, which includes UlcerGard, GastroGard, Zimecterin, Equioxx, Eqvalen, Imrab, the RecombiTEK vaccines and the updated Proteqflu vaccine for equine influenza. 

Merial is owned by Sanofi, who is headquartered in Paris.

Login to save this for later


3 years ago
sounds like a monopoly starting on the horse people

Login or Register Here now to post a comment

FREE Horse Journal Email Newsletter

My Articles

Copyright 2017 by Cruz Bay Publishing, Inc. an Active Interest Media company